Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cohort profile: investigating SARS-CoV-2 infection and the health and psychosocial impact of the COVID-19 pandemic in the Canadian CHILD Cohort.
Azeez R, Lotoski L, Dubeau A, Rodriguez N, Reyna ME, Freitas T, Goguen S, Medeleanu M, Winsor GL, Brinkman FSL, Cameron EE, Roos L, Simons E, Moraes TJ, Mandhane PJ, Turvey SE, Bolotin S, Wright K, McNeil D, Patrick DM, Bullard J, Langlois MA, Arnold CR, Galipeau Y, Pelchat M, Doucas N, Subbarao P, Azad MB. Azeez R, et al. Among authors: langlois ma. Epidemiol Health. 2023;45:e2023091. doi: 10.4178/epih.e2023091. Epub 2023 Oct 13. Epidemiol Health. 2023. PMID: 37857338 Free PMC article.
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.
Keeshan A, Galipeau Y, Heiskanen A, Collins E, McCluskie PS, Arnold C, Saginur R, Booth R, Little J, McGuinty M, Buchan CA, Crawley A, Langlois MA, Cooper C. Keeshan A, et al. Among authors: langlois ma. BMJ Open. 2023 Oct 31;13(10):e077714. doi: 10.1136/bmjopen-2023-077714. BMJ Open. 2023. PMID: 37907304 Free PMC article.
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study.
Almeida ND, Schiller I, Ke D, Sakr E, Plesa M, Vanamala S, Moneger AL, Bazan M, Lucchesi C, Wozniak N, Fritz JH, Piccirillo CA, Pelchat M, Arnold C, Galipeau Y, McCluskie PS, Langlois MA, Dasgupta K, Mazer BD. Almeida ND, et al. Among authors: langlois ma. Front Immunol. 2024 Feb 16;15:1330549. doi: 10.3389/fimmu.2024.1330549. eCollection 2024. Front Immunol. 2024. PMID: 38433831 Free PMC article.
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness.
Shaver N, Katz M, Darko Asamoah G, Linkins LA, Abdelkader W, Beck A, Bennett A, Hughes SE, Smith M, Begin M, Coyle D, Piggott T, Kagina BM, Welch V, Colijn C, Earn DJD, El Emam K, Heffernan J, O'Brien SF, Wilson K, Collins E, Navarro T, Beyene J, Boutron I, Bowdish D, Cooper C, Costa A, Curran J, Griffith L, Hsu A, Grimshaw J, Langlois MA, Li X, Pham-Huy A, Raina P, Rubini M, Thabane L, Wang H, Xu L, Brouwers M, Horsley T, Lavis J, Iorio A, Little J. Shaver N, et al. Among authors: langlois ma. Vaccine. 2023 Oct 13;41(43):6411-6418. doi: 10.1016/j.vaccine.2023.09.012. Epub 2023 Sep 16. Vaccine. 2023. PMID: 37718186 Free article. Review.
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series.
Colmegna I, Valerio V, Amiable N, Useche M, Rampakakis E, Flamand L, Rollet-Labelle E, Bessette L, Fitzcharles MA, Hazel E, McCormack D, Michou L, Panopalis P, Langlois MA, Bernatsky S, Fortin PR. Colmegna I, et al. Among authors: langlois ma. RMD Open. 2023 Nov 29;9(4):e003400. doi: 10.1136/rmdopen-2023-003400. RMD Open. 2023. PMID: 38030231 Free PMC article. Clinical Trial.
Serological markers and long COVID-A rapid systematic review.
Collins E, Philippe E, Gravel CA, Hawken S, Langlois MA, Little J. Collins E, et al. Among authors: langlois ma. Eur J Clin Invest. 2024 Apr;54(4):e14149. doi: 10.1111/eci.14149. Epub 2023 Dec 11. Eur J Clin Invest. 2024. PMID: 38083997 Review.
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Ku'ulei-Lyn Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ; MISEV Consortium; Théry C, Witwer KW. Welsh JA, et al. J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404. J Extracell Vesicles. 2024. PMID: 38326288 Free PMC article.
The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.
Murphy TJ, Swail H, Jain J, Anderson M, Awadalla P, Behl L, Brown PE, Charlton CL, Colwill K, Drews SJ, Gingras AC, Hinshaw D, Jha P, Kanji JN, Kirsh VA, Lang ALS, Langlois MA, Lee S, Lewin A, O'Brien SF, Pambrun C, Skead K, Stephens DA, Stein DR, Tipples G, Van Caeseele PG, Evans TG, Oxlade O, Mazer BD, Buckeridge DL. Murphy TJ, et al. Among authors: langlois ma. CMAJ. 2023 Aug 14;195(31):E1030-E1037. doi: 10.1503/cmaj.230249. CMAJ. 2023. PMID: 37580072 Free PMC article.
81 results